Pulmatrix, Inc. carries no debt; cash flow comfortably covers obligations.

Pulmatrix, Inc.'s free cash flow has increased -51.12% from $-11.11M last year to $-5.43M, signaling increasing performance

Pulmatrix, Inc.'s debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability.

Pulmatrix, Inc. has insufficient data to evaluate this check.

Pulmatrix, Inc. has a net cash position, so leverage is healthy.

Pulmatrix, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Pulmatrix, Inc.'s profit margin has increased (-100.00%) in the last year from -122.46% to 0.00%, signaling increasing performance

Pulmatrix, Inc.'s short-term assets of $4.13M exceed its short-term liabilities of $329.00K

Pulmatrix, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Pulmatrix, Inc.'s return on equity of -102.06%, is lower than 15.00%, indicating bad performance

Pulmatrix, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Pulmatrix, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

Pulmatrix, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Pulmatrix, Inc. has negative free cash flow, indicating cash burn

Pulmatrix, Inc.'s yearly earnings has increased -46.00% since last year from $-9.56M to $-5.16M, signaling increasing performance

Pulmatrix, Inc.'s yearly revenue has decreased 100.00% since last year from $7.81M to $0.00, signaling decreasing performance

ROIC -128.49% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Pulmatrix, Inc.'s 3-year revenue CAGR of -100.00% is negative, indicating declining revenue over the past 3 years

Pulmatrix, Inc. had revenue growth in 3 out of 5 years, indicating consistent revenue performance

Pulmatrix, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Pulmatrix, Inc. has insufficient data to evaluate this check.

Pulmatrix, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Pulmatrix, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Pulmatrix, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Pulmatrix, Inc. has insufficient data to evaluate this check.

Pulmatrix, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Pulmatrix, Inc. has a price-to-book ratio of 1.60x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Pulmatrix, Inc. has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue